Impact of oxygen availability on body weight management

Medical Hypotheses

Volumn 74, Issue 5, 2010, Pages 901-907

  Quintero, P ^a   Milagro, F I ^a   Campion J ^a   Martinez J A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADIPOSE TISSUE; ALTITUDE; APPETITE; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC INFLAMMATION; HOMEOSTASIS; HUMAN; HYPEROXIA; HYPOTHESIS; HYPOXIA; INCIDENCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN THERAPY; OXYGENATION; PUBLIC HEALTH PROBLEM; RISK FACTOR; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADIPOSE TISSUE; ANOXIA; BIOLOGICAL AVAILABILITY; HUMANS; HYPEROXIA; OBESITY; OXYGEN; WEIGHT LOSS;

ANIMALIA;

EID: 77951022278     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.022     Document Type: Article

References (105)

1. James W.P. The fundamental drivers of the obesity epidemic. Obes Rev 2008, 9(Suppl. 1):6-13.
2. WHO. Fact sheet: obesity and overweight. [accessed 11.05.2009]. http://www.who.int/mediacentre/factsheets/fs311/en/print.html.
3. Marti A., Martinez-Gonzalez M.A., Martinez J.A. Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc 2008, 67:1-8.
4. Lois K., Young J., Kumar S. Obesity; epiphenomenon or cause of metabolic syndrome?. Int J Clin Pract 2008, 62:932-938.
5. Misra A., Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008, 93:S9-S30.
6. Shukla V., Singh S.N., Vats P., Singh V.K., Singh S.B., Banerjee P.K. Ghrelin and leptin levels of sojourners and acclimatized lowlanders at high altitude. Nutr Neurosci 2005, 8:161-165.
7. Westerterp K.R., Kayser B., Wouters L., Le Trong J.L., Richalet J.P. Energy balance at high altitude of 6542m. J Appl Physiol 1994, 77:862-866.
8. Westerterp-Plantenga M.S., Westerterp K.R., Rubbens M., Verwegen C.R., Richelet J.P., Gardette B. Appetite at " high altitude" [Operation Everest III (Comex-'97)]: a simulated ascent of Mount Everest. J Appl Physiol 1999, 87:391-399.
9. Martinez J.A. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J Physiol Biochem 2006, 62:303-306.
10. Rosen A., Casciola-Rosen L. Stem cells in inflammatory disease. Curr Opin Rheumatol 2006, 18:618-619.
11. Yudkin J.S. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 2003, 27(Suppl. 3):S25-S28.
12. Hosogai N., Fukuhara A., Oshima K., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
13. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
14. Perez-Matute P., Zulet M.A., Martinez J.A. Reactive species and diabetes: counteracting oxidative stress to improve health. Curr Opin Pharmacol 2009.
15. Fleischmann E., Kurz A., Niedermayr M., et al. Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg 2005, 15:813-819.
16. Kabon B., Nagele A., Reddy D., et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004, 100:274-280.
17. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
18. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009, 33:54-66.
19. Yin J., Gao Z., He Q., Zhou D., Guo Z., Ye J. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 2009, 296:E333-E342.
20. Albina J.E., Mastrofrancesco B., Vessella J.A., Louis C.A., Henry W.L., Reichner J.S. HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol 2001, 281:C1971-C1977.
21. Jung Y., Isaacs J.S., Lee S., Trepel J., Liu Z.G., Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J 2003, 370:1011-1017.
22. Kim V., Benditt J.O., Wise R.A., Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:513-518.
23. Kalani M., Jorneskog G., Naderi N., Lind F., Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complicat 2002, 16:153-158.
24. Matchett G.A., Martin R.D., Zhang J.H. Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms. Neurol Res 2009, 31:114-121.
25. Nilles E., Sayward H., D'Onofrio G. Vascular endothelial growth factor and acute mountain sickness. J Emerg Trauma Shock 2009, 2:6-9.
26. Westerterp K.R. Energy and water balance at high altitude. News Physiol Sci 2001, 16:134-137.
27. Hamad N., Travis S.P. Weight loss at high altitude: pathophysiology and practical implications. Eur J Gastroenterol Hepatol 2006, 18:5-10.
28. Tschop M., Strasburger C.J., Topfer M., et al. Influence of hypobaric hypoxia on leptin levels in men. Int J Obes Relat Metab Disord 2000, 24(Suppl. 2):S151.
29. Snyder E.M., Carr R.D., Deacon C.F., Johnson B.D. Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans. Appl Physiol Nutr Metab 2008, 33:929-935.
30. Chaiban J.T., Bitar F.F., Azar S.T. Effect of chronic hypoxia on leptin, insulin, adiponectin, and ghrelin. Metabolism 2008, 57:1019-1022.
31. Ling Q., Sailan W., Ran J., et al. The effect of intermittent hypoxia on bodyweight, serum glucose and cholesterol in obesity mice. Pak J Biol Sci 2008, 11:869-875.
32. Ducsay C.A., Hyatt K., Mlynarczyk M., Kaushal K.M., Myers D.A. Long-term hypoxia increases leptin receptors and plasma leptin concentrations in the late-gestation ovine fetus. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1406-R1413.
33. Ambrosini G., Nath A.K., Sierra-Honigmann M.R., Flores-Riveros J. Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem 2002, 277:34601-34609.
34. Grosfeld A., Andre J., Hauguel-De Mouzon S., Berra E., Pouyssegur J., Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002, 277:42953-42957.
35. Benoit S.C., Clegg D.J., Seeley R.J., Woods S.C. Insulin and leptin as adiposity signals. Recent Prog Horm Res 2004, 59:267-285.
36. Yasumasu T., Takahara K., Nakashima Y. Hypoxia inhibits leptin production by cultured rat adipocytes. Obes Res 2002, 10:128.
37. Wang B., Wood I.S., Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 2008, 198:127-134.
38. Vats P., Singh V.K., Singh S.N., Singh S.B. High altitude induced anorexia: effect of changes in leptin and oxidative stress levels. Nutr Neurosci 2007, 10:243-249.
39. Simler N., Grosfeld A., Peinnequin A., Guerre-Millo M., Bigard A.X. Leptin receptor-deficient obese Zucker rats reduce their food intake in response to hypobaric hypoxia. Am J Physiol Endocrinol Metab 2006, 290:E591-E597.
40. Blundell J.E., Naslund E. Glucagon-like peptide-1, satiety and appetite control. Br J Nutr 1999, 81:259-260.
41. Flint A., Raben A., Astrup A., Holst J.J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998, 101:515-520.
42. Gutzwiller J.P., Goke B., Drewe J., et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999, 44:81-86.
43. Naslund E., Gutniak M., Skogar S., Rossner S., Hellstrom P.M. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 1998, 68:525-530.
44. Iiyori N., Alonso L.C., Li J., et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007, 175:851-857.
45. Boyer S.J., Blume F.D. Weight loss and changes in body composition at high altitude. J Appl Physiol 1984, 57:1580-1585.
46. Kayser B., Acheson K., Decombaz J., Fern E., Cerretelli P. Protein absorption and energy digestibility at high altitude. J Appl Physiol 1992, 73:2425-2431.
47. Kleessen B., Schroedl W., Stueck M., Richter A., Rieck O., Krueger M. Microbial and immunological responses relative to high-altitude exposure in mountaineers. Med Sci Sports Exerc 2005, 37:1313-1318.
48. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002, 64:993-998.
49. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 1999, 274:6519-6525.
50. Sutter C.H., Laughner E., Semenza G.L. Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci USA 2000, 97:4748-4753.
51. Dehne N., Brune B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 2009, 315:1791-1797.
52. Karpe F., Fielding B.A., Ilic V., Macdonald I.A., Summers L.K., Frayn K.N. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002, 51:2467-2473.
53. Trayhurn P., Wang B., Wood I.S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?. Br J Nutr 2008, 100:227-235.
54. Wang B., Wood I.S., Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007, 455:479-492.
55. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007, 293:E1118-E1128.
56. Regazzetti C., Peraldi P., Gremeaux T., et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009, 58:95-103.
57. Wood I.S., de Heredia F.P., Wang B., Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009, 1-8.
58. Morel O.E., Aubert R., Richalet J.P., Chapelot D. Simulated high altitude selectively decreases protein intake and lean mass gain in rats. Physiol Behav 2005, 86:145-153.
59. Bigard A.X., Douce P., Merino D., Lienhard F., Guezennec C.Y. Changes in dietary protein intake fail to prevent decrease in muscle growth induced by severe hypoxia in rats. J Appl Physiol 1996, 80:208-215.
60. Reynolds R.D., Lickteig J.A., Deuster P.A., et al. Energy metabolism increases and regional body fat decreases while regional muscle mass is spared in humans climbing Mt. Everest. J Nutr 1999, 129:1307-1314.
61. Tanaka M., Mizuta K., Koba F., Ohira Y., Kobayashi T., Honda Y. Effects of exposure to hypobaric-hypoxia on body weight, muscular and hematological characteristics, and work performance in rats. Jpn J Physiol 1997, 47:51-57.
62. Martinez D., Vasconcellos L.F., de Oliveira P.G., Konrad S.P. Weight loss and brown adipose tissue reduction in rat model of sleep apnea. Lipids Health Dis 2008, 7:26.
63. Toyama T., Seki R., Kasama S., et al. Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. Circ J 2009, 73:299-304.
64. UHMS, Hyperbaric oxygen therapy indications; 2008.
65. Bennett M.H., Feldmeier J., Hampson N., Smee R., Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev 2005, CD005005.
66. Bennett M., Feldmeier J., Smee R., Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database Syst Rev 2005, CD005007.
67. Kiralp M.Z., Uzun G., Dincer O., et al. A novel treatment modality for myofascial pain syndrome: hyperbaric oxygen therapy. J Natl Med Assoc 2009, 101:77-80.
68. Broussard C.L. Hyperbaric oxygenation and wound healing. J Vasc Nurs 2004, 22:42-48.
69. Ong M. Hyperbaric oxygen therapy in the management of diabetic lower limb wounds. Singapore Med J 2008, 49:105-109.
70. Chiu E.H., Liu C.S., Tan T.Y., Chang K.C. Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch Neurol 2006, 63:741-744.
71. Kim H.Y., Singhal A.B., Lo E.H. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol 2005, 57:571-575.
72. Singhal A.B., Ratai E., Benner T., et al. Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Stroke 2007, 38:2851-2854.
73. Singhal A.B., Benner T., Roccatagliata L., et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005, 36:797-802.
74. Tisdall M.M., Tachtsidis I., Leung T.S., Elwell C.E., Smith M. Increase in cerebral aerobic metabolism by normobaric hyperoxia after traumatic brain injury. J Neurosurg 2008, 109:424-432.
75. Chaves J.C., Fagundes D.J., Simoes M.D., et al. Hyperbaric oxygen therapy protects the liver from apoptosis caused by ischemia-reperfusion injury in rats. Microsurgery 2009.
76. Bigdeli M.R., Hajizadeh S., Froozandeh M., Rasulian B., Heidarianpour A., Khoshbaten A. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res 2007, 1152:228-233.
77. Ercin C.N., Yesilova Z., Korkmaz A., Ozcan A., Oktenli C., Uygun A. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci 2009, 54:75-79.
78. Efrati S., Berman S., Ben Aharon G., Siman-Tov Y., Averbukh Z., Weissgarten J. Application of normobaric hyperoxia therapy for amelioration of haemorrhagic shock-induced acute renal failure. Nephrol Dial Transplant 2008, 23:2213-2222.
79. Barazzone-Argiroffo C., Muzzin P., Donati Y.R., Kan C.D., Aubert M.L., Piguet P.F. Hyperoxia increases leptin production: a mechanism mediated through endogenous elevation of corticosterone. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1150-L1156.
80. Bellmeyer A., Martino J.M., Chandel N.S., Scott Budinger G.R., Dean D.A., Mutlu G.M. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2007, 175:587-594.
81. Loffreda S., Yang S.Q., Lin H.Z., et al. Leptin regulates proinflammatory immune responses. FASEB J 1998, 12:57-65.
82. Brueckl C., Kaestle S., Kerem A., et al. Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol 2006, 34:453-463.
83. Yzydorczyk C., Comte B., Cambonie G., et al. Neonatal oxygen exposure in rats leads to cardiovascular and renal alterations in adulthood. Hypertension 2008, 52:889-895.
84. Wijkstra P.J., Guyatt G.H., Ambrosino N., et al. International approaches to the prescription of long-term oxygen therapy. Eur Respir J 2001, 18:909-913.
85. Capellier G., Maupoil V., Boussat S., Laurent E., Neidhardt A. Oxygen toxicity and tolerance. Minerva Anestesiol 1999, 65:388-392.
86. Barazzone C., Tacchini-Cottier F., Vesin C., Rochat A.F., Piguet P.F. Hyperoxia induces platelet activation and lung sequestration: an event dependent on tumor necrosis factor-alpha and CD11a. Am J Respir Cell Mol Biol 1996, 15:107-114.
87. Jensen J.C., Pogrebniak H.W., Pass H.I., et al. Role of tumor necrosis factor in oxygen toxicity. J Appl Physiol 1992, 72:1902-1907.
88. Johnston C.J., Wright T.W., Reed C.K., Finkelstein J.N. Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res 1997, 23:537-552.
89. Piedboeuf B., Horowitz S., Johnston C.J., et al. Interleukin-1 expression during hyperoxic lung injury in the mouse. Free Radic Biol Med 1998, 24:1446-1454.
90. 2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res 1995, 21:589-597.
91. Desmarquest P., Chadelat K., Corroyer S., Cazals V., Clement A. Effect of hyperoxia on human macrophage cytokine response. Respir Med 1998, 92:951-960.
92. Weisz G., Lavy A., Adir Y., et al. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 1997, 17:154-159.
93. Lahat N., Bitterman H., Yaniv N., Kinarty A., Bitterman N. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clin Exp Immunol 1995, 102:655-659.
94. Benson R.M., Minter L.M., Osborne B.A., Granowitz E.V. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol 2003, 134:57-62.
95. Yamashita M., Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol Endocrinol Metab 2000, 278:E811-E816.
96. Luongo C., Imperatore F., Cuzzocrea S., et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 1998, 26:1972-1976.
97. 2 reduces intestinal ischemia-reperfusion-induced TNF-alpha production and lung neutrophil sequestration. Eur J Appl Physiol 2001, 85:96-103.
98. Allahdadi K.J., Walker B.R., Kanagy N.L. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005, 45:705-709.
99. Chen L., Einbinder E., Zhang Q., Hasday J., Balke C.W., Scharf S.M. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 2005, 172:915-920.
100. Dematteis M., Julien C., Guillermet C., et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008, 177:227-235.
101. Dunleavy M., Dooley M., Cox D., Bradford A. Chronic intermittent asphyxia increases platelet reactivity in rats. Exp Physiol 2005, 90:411-416.
102. Joyeux-Faure M., Stanke-Labesque F., Lefebvre B., et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 2005, 98:1691-1696.
103. Polotsky V.Y., Li J., Punjabi N.M., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003, 552:253-264.
104. Zoccal D.B., Simms A.E., Bonagamba L.G., et al. Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J Physiol 2008, 586:3253-3265.
105. Cordero P., Solomon A., Martinez J.A. Efficiency and mitochondrial metabolism: an etiological axis for obesity?. Rev Med Univ Navarra 2007, 51:13-18.